Interview with Magdalena Cardinal, president of the OmeaLife Foundation
Access to new therapies is a chance of a lifetime for breast cancer patients
Published May 3, 2023 10:00
- Breast cancer patients need new therapies that we know are already available worldwide.
- We need the therapies for perioperative treatment in earlier indications. For the patient, this means a chance at life, meaning either a complete cure or an extended time to progression.
- There is also a lack of accessibility to genetic testing. The demand for access to them stems from global recommendations.
- There is also a need for access to personalized breast surgery and oncoplastic techniques.
